Pharmacological treatment of insomnia in alcohol recovery: A systematic review

Alcohol and Alcoholism

Volumn 46, Issue 5, 2011, Pages 578-585

  Kolla, Bhanu Prakash ^a   Mansukhani, Meghna Prabhdas ^a   Schneekloth, Terry ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BENZODIAZEPINE; CARBAMAZEPINE; CLOMETHIAZOLE; DIAZEPAM; FLUMAZENIL; GABAPENTIN; GAMMA GLUTAMYLTRANSFERASE; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; LORMETAZEPAM; MAGNESIUM; MELPERONE; PLACEBO; QUETIAPINE; RITANSERIN; SCOPOLAMINE; TEMAZEPAM; TETRABAMATE; TOPIRAMATE; TRAZODONE; TRIAZOLAM; VALPROIC ACID; ZOPICLONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEDTIME DOSAGE; DETOXIFICATION; DISEASE SEVERITY; DRINKING BEHAVIOR; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INSOMNIA; MEAN CORPUSCULAR VOLUME; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; SIDE EFFECT; SLEEP DISORDER; SLEEP QUALITY; SYSTEMATIC REVIEW; TREATMENT DURATION;

ALCOHOLISM; AMINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CYCLOHEXANECARBOXYLIC ACIDS; ETHANOL; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPNOTICS AND SEDATIVES; MAGNESIUM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP INITIATION AND MAINTENANCE DISORDERS; TAURINE; TRAZODONE;

EID: 80052000649     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agr073     Document Type: Article

References (43)

1. Ansoms S, Lebon O, Pelc I et al. (1991) Zopiclone or lormetazepam in the treatment of insomnia and the effect on behavior and mood in patients during the post alcoholism withdrawal period. Curr Ther Res Clin Exp 49:54-64.
2. Anton RF, Myrick H, Baros A et al. (2009) Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol 29:334-42.
3. Arnedt J, Conroy D, Brower K. (2007) Treatment options for sleep disturbances during alcohol recovery. J Addict Dis 26:41-54.
4. Aubin H-J, Goldenberg F, Benoit O et al. (1994) Effects of tetrabamate and of diazepam on sleep polygraphy during subacute withdrawal in alcohol-dependent patients. Hum Psychopharmacol 9:191-5.
5. Bjorkqvist S, Isohanni M, Makela R et al. (1976) Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre double-blind comparison with placebo. Acta Psychiatr Scand 53:333-42.
6. Boothby LA, Doering PL. (2005) Acamprosate for the treatment of alcohol dependence. Clin Ther 27:695-714.
7. Brower KJ. (2001) Alcohol's effects on sleep in alcoholics. Alcohol Res Health 25:110-25.
8. Brower KJ. (2003) Insomnia, alcoholism and relapse. Sleep Med Rev 7:523-39.
9. Brower K, Aldrich M, Robinson E et al. (2001) Insomnia, selfmedication, and relapse to alcoholism. Am J Psychiatry 158:399-404.
10. Brower K, Myra Kim H, Strobbe S et al. (2008) A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res 32:1429-38.
11. Buysse D, Reynolds Cr, Monk T et al. (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213.
12. Carlsson C, Gullberg B. (1978) A double blind study with melperone and placebo in the treatment of chronic alcoholics. Int J Clin Pharmacol Biopharm 16:331-2.
13. Cohn T, Foster J, Peters T. (2003) Sequential studies of sleep disturbance and quality of life in abstaining alcoholics. Addict Biol 8:455-62.
14. Drummond S, Gillin J, Smith T et al. (1998) The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res 22:1796-802.
15. Fabre LF, Gainey A, Kemple S et al. (1977) Pilot open-label study of triazolam in the treatment of insomnia following alcohol withdrawal. J Stud Alcohol 38:2188-92.
16. Foster JH, Marshall EJ, Peters TJ. (1998) Predictors of relapse to heavy drinking in alcohol dependent subjects following alcohol detoxification-the role of quality of life measures, ethnicity, social class, cigarette and drug use. Addict Biol 3:333-43.
17. Foy A, March S, Drinkwater V. (1988) Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital. Alcohol Clin Exp Res 12:360-4.
18. Friedmann P, Herman D, Freedman S et al. (2003) Treatment of sleep disturbance in alcohol recovery: a national survey of addiction medicine physicians. J Addict Dis 22:91-103.
19. Friedmann P, Rose J, Swift R et al. (2008) Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebocontrolled trial. Alcohol Clin Exp Res 32:1652-60.
20. Furieri F, Nakamura-Palacios E. (2007) Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebocontrolled trial. J Clin Psychiatry 68:1691-700.
21. Gann H, Feige B, Cloot O et al. (2004) Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients-a double-blind and randomized study. Pharmacopsychiatry 37:228-35.
22. Gillin JC, Sutton L, Ruiz C et al. (1991) The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group. Biol Psychiatry 30:157-69.
23. Gillin JC, Smith TL, Irwin M et al. (1994) Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in non-depressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry 51:189-97.
24. Guy W. (1976) Clinical global impression. ECDEU Assessment Manual for Psychopharmacology, Rockville, MD: U.S. Department of Health, Education, and Welfare, 217-22.
25. Hajak G, Müller W, Wittchen H et al. (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98:1371-8.
26. Hornyak M, Haas P, Veit J et al. (2004) Magnesium treatment of primary alcohol-dependent patients during subacute withdrawal: an open pilot study with polysomnography. Alcohol Clin Exp Res 28:1702-9.
27. ICSD (2005) The International Classification of Sleep Disorders-Second Edition. Westchester, IL: American Academy of Sleep Medicine.
28. Jenkins C, Stanton B, Niemcryk S et al. (1988) A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 41:313-21.
29. Johnson BA, Rosenthal N, Capece JA et al. (2008) Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med 168:1188-99.
30. Karam-Hage M, Brower KJ. (2003) Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients. Psychiatry Clin Neurosci 57:542-4.
31. Kolla B, Schneekloth T, Biernacka J et al. (2011) Trazodone and alcohol relapse: a retrospective study of a residential treatment center. Am J Addict (in press).
32. Le Bon O, Murphy JR, Staner L et al. (2003) Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol 23:377-83.
33. Malcolm R, Myrick H, Roberts J et al. (2002) The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 17:349-55.
34. Mariani JJ, Rosenthal RN, Tross S et al. (2006) A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. Am J Addict 15:76-84.
35. Markowitz JS, Finkenbine R, Myrick H et al. (1997) Gabapentin abuse in a cocaine user: implications for treatment? J Clin Psychopharmacol 17:423-5.
36. Martinotti G, Andreoli S, Di Nicola M et al. (2008) Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Hum Psychopharmacol 23:417-24.
37. Monti JM, Alterwain P, Estevez F et al. (1993) The effects of ritanserin on mood and sleep in abstinent alcoholic patients. Sleep 16:647-54.
38. Myrick H, Anton R, Voronin K (2007) A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res 31:221-7.
39. Myrick H, Malcolm R, Randall PK et al. (2009) A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res 33:1582-8.
40. Sansone RA, Sansone LA. (2010) Is seroquel developing an illicit reputation for misuse/abuse?. Psychiatry (Edgmont) 7:13-6.
41. Schmitz M, Frey R, Pichler P et al. (1997) Sleep quality during alcohol withdrawal with bright light therapy. Prog Neuropsychopharmacol Biol Psychiatry 21:965-77.
42. Staner L, Boeijinga P, Danel T et al. (2006) Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebocontrolled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res 30:1492-9.
43. Trevisan LA, Ralevski E, Keegan K et al. (2008) Alcohol detoxification and relapse prevention using valproic acid versus gabapentin in alcohol-dependent patients. Addict Disord Their Treat 7:119-28.